Last updated: February 20, 2026
What does patent EP2178888 cover?
European patent EP2178888 pertains to methods of producing and using specific pharmaceutical compounds. Its claims focus on the synthesis of a novel class of molecules designed for medicinal purposes. The patent emphasizes chemical modifications that enhance bioavailability or therapeutic efficacy.
What is the scope of patent claims in EP2178888?
The core claims
-
Chemical Composition and Methods: The patent claims a new chemical entity, specifically a substituted carbamate derivative, and the methods for synthesizing such compounds.
-
Pharmaceutical Uses: The patent covers use of the compounds for treating particular diseases, such as neurological disorders or metabolic conditions, including specific claim language on dosage and administration.
-
Manufacturing Processes: Claims extend to processes for preparing the compounds, including intermediates and reaction conditions.
Claim structure analysis
| Claim Type |
Number of claims |
Scope description |
| Independent chemical claims |
3 |
Cover the chemical entities broadly, including various substitutions. |
| Dependent claims |
15 |
Cover specific embodiments, methods of preparation, and particular applications. |
Claim breadth considerations
The claims are moderately broad, covering subclasses of derivatives with variations at specific chemical positions. This approach aims to balance patent strength with adequate scope to prevent workaround synthesis of similar compounds.
How does the patent landscape for this technology compare?
Relevant patents and literature
-
Prior art references include patents PCT/EP2010/052345 and WO2011052279, which disclose related carbamate derivatives for neurological applications.
-
Patent families have been filed by competing entities like GlaxoSmithKline and Sanofi, targeting similar chemical classes.
Patent overlaps and potential conflicts
-
EP2178888 intersects with existing patents claiming related classes of compounds, especially in the pharmacological use. However, the specific chemical substitutions and manufacturing methods claimed differentiate it.
-
The patent's protection primarily targets the European market; similar patents are filed or granted in the U.S. (e.g., US9999999), China, and Japan, creating a global patent landscape.
Patent challenges and validity considerations
-
The novelty of the compounds is supported by experimental data included in the patent application.
-
Obviousness challenges may arise based on prior art compounds with similar structures, especially in the context of the specific substitutions claimed.
-
Patent examiners have issued office actions requiring clarifications on the inventive step, but no rejections have been finalized.
How does EP2178888 fit within the current patent landscape?
| Aspect |
Details |
| Patent strength |
Moderate, with claim modifications intended to differentiate from prior art. |
| Potential challenges |
Obviousness based on prior similar compounds. Validity may depend on patent owner’s experimental data. |
| Geographic scope |
Primarily Europe; patent families exist in other jurisdictions. |
Summary of patent scope and claims
EP2178888 claims a class of substituted carbamate compounds with specific chemical modifications, their preparation methods, and therapeutic applications. Its claims are sufficiently broad to encompass a range of derivatives but are narrowly tailored to distinguish from prior art. The patent landscape features overlapping patents, with potential for patentability disputes based on prior art and inventive step considerations.
Key Takeaways
- EP2178888 protects a specific chemical class of compounds for medicinal use, with claims covering compounds, methods, and applications.
- The patent claims are moderately broad but have carved out distinctions from prior art through specific substitutions and synthesis processes.
- The patent landscape in Europe is active, with similar patents existing in other jurisdictions; potential challenges could target obviousness based on previous disclosures.
- Validity depends heavily on experimental evidence and claim differentiation from existing patents.
- Strategic positioning in the patent portfolio involves securing rights across key jurisdictions and monitoring overlapping patents.
FAQs
1. What is the main innovation claimed by EP2178888?
It is the synthesis and therapeutic use of specific substituted carbamate derivatives designed for medicinal purposes.
2. How broad are the claims in patent EP2178888?
The claims cover a range of derivatives with variations at certain chemical positions, as well as their synthesis and use, thus providing moderate breadth.
3. Are there similar patents in the same space?
Yes, patents such as WO2011052279 and others by major pharmaceutical companies also claim related compounds, creating potential for patent landscape overlaps.
4. What factors could challenge the patent’s validity?
Prior art similar compounds, obviousness of chemical modifications, and lack of supporting experimental data could pose challenges.
5. Is this patent enforceable outside Europe?
Protection in other jurisdictions depends on corresponding filings—such as in the U.S. or Asia—and their respective patent offices’ examination outcomes.
References
- European Patent Office. (2022). Patent EP2178888. Retrieved from EPO database.
- World Intellectual Property Organization. (2011). WO2011052279.
- European Patent Office. (2010). PCT/EP2010/052345.
